Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis.

Choi KH, Seo WK, Park MS, Kim JT, Chung JW, Bang OY, Kim GM, Song TJ, Kim BJ, Heo SH, Jung JM, Oh K, Kim CK, Yu S, Park KY, Kim JM, Park JH, Choi JC, Hwang YH, Kim YJ.

J Clin Med. 2019 Sep 13;8(9). pii: E1457. doi: 10.3390/jcm8091457.

2.

D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.

Christersson C, Wallentin L, Andersson U, Alexander JH, Ansell J, De Caterina R, Gersh BJ, Granger CB, Hanna M, Horowitz JD, Huber K, Husted S, Hylek EM, Lopes RD, Siegbahn A.

J Thromb Haemost. 2014 Sep;12(9):1401-12. doi: 10.1111/jth.12638. Epub 2014 Jul 24.

3.

Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack.

Li J, Liu J, Liu M, Zhang S, Hao Z, Zhang J, Zhang C.

Cochrane Database Syst Rev. 2015 Sep 8;(9):CD009938. doi: 10.1002/14651858.CD009938.pub2. Review.

PMID:
26346232
4.

Carotid atherosclerosis and risk for ischemic stroke in patients with atrial fibrillation on oral anticoagulant treatment.

Becattini C, Dentali F, Camporese G, Sembolini A, Rancan E, Tonello C, Manina G, Padayattil S, Agnelli G.

Atherosclerosis. 2018 Apr;271:177-181. doi: 10.1016/j.atherosclerosis.2018.02.004. Epub 2018 Mar 2.

PMID:
29524860
5.

Non-permanent atrial fibrillation and oral anticoagulant therapy are related to survival during 10years after first-ever ischemic stroke.

Baturova MA, Lindgren A, Carlson J, Shubik YV, Bertil Olsson S, Platonov PG.

Int J Cardiol. 2017 Apr 1;232:134-139. doi: 10.1016/j.ijcard.2017.01.040. Epub 2017 Jan 5.

PMID:
28132778
6.
7.

Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.

Abdul-Jawad Altisent O, Durand E, Muñoz-García AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benítez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elízaga J, Dager A, García Del Blanco B, Ortas-Nadal Mdel R, Marsal JR, Campelo-Parada F, Regueiro A, Del Trigo M, Dumont E, Puri R, Rodés-Cabau J.

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1706-17. doi: 10.1016/j.jcin.2016.06.025.

8.

Serum D-dimer Levels Are Proportionally Associated with Left Atrial Enlargement in Patients with an Acute Ischemic Stroke due to Non-valvular Atrial Fibrillation.

Kim TW, Song IU, Chung SW, Kim JS, Koo J, Lee KS.

Intern Med. 2016;55(11):1447-52. doi: 10.2169/internalmedicine.55.6087. Epub 2016 Jun 1.

9.

Antithrombotic therapy after acute ischemic stroke in patients with atrial fibrillation.

McGrath ER, Kapral MK, Fang J, Eikelboom JW, Conghaile Aó, Canavan M, O'Donnell MJ; Investigators of the Ontario Stroke Registry.

Stroke. 2014 Dec;45(12):3637-42. doi: 10.1161/STROKEAHA.114.006929. Epub 2014 Nov 6. Erratum in: Stroke. 2016 Jan;47(1):e20. Conghaile, Aengus O [corrected to Conghaile, Aengus ó].

PMID:
25378422
10.

Relation of effective anticoagulation in patients with atrial fibrillation to stroke severity and survival (from the National Acute Stroke Israeli Survey [NASIS]).

Schwammenthal Y, Bornstein N, Schwammenthal E, Schwartz R, Goldbourt U, Tsabari R, Koton S, Grossman E, Tanne D.

Am J Cardiol. 2010 Feb 1;105(3):411-6. doi: 10.1016/j.amjcard.2009.09.050. Epub 2009 Dec 22.

PMID:
20102959
11.

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention.

Lamberts M, Gislason GH, Olesen JB, Kristensen SL, Schjerning Olsen AM, Mikkelsen A, Christensen CB, Lip GY, Køber L, Torp-Pedersen C, Hansen ML.

J Am Coll Cardiol. 2013 Sep 10;62(11):981-9. doi: 10.1016/j.jacc.2013.05.029. Epub 2013 Jun 7.

12.

Elevated Plasma D-Dimer Level Is Associated With Short-Term Risk of Ischemic Stroke in Patients With Acute Heart Failure.

Hamatani Y, Nagai T, Nakai M, Nishimura K, Honda Y, Nakano H, Honda S, Iwakami N, Sugano Y, Asaumi Y, Aiba T, Noguchi T, Kusano K, Toyoda K, Yasuda S, Yokoyama H, Ogawa H, Anzai T; NaDEF Investigators.

Stroke. 2018 Jul;49(7):1737-1740. doi: 10.1161/STROKEAHA.118.021899. Epub 2018 Jun 7.

PMID:
29880555
13.
14.

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.

Nielsen PB, Larsen TB, Skjøth F, Gorst-Rasmussen A, Rasmussen LH, Lip GY.

Circulation. 2015 Aug 11;132(6):517-25. doi: 10.1161/CIRCULATIONAHA.115.015735. Epub 2015 Jun 9. Erratum in: Circulation. 2017 Feb 14;135(7):e48.

PMID:
26059010
15.

Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.

Choi HI, Ahn JM, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.

JACC Cardiovasc Interv. 2017 Jun 12;10(11):1075-1085. doi: 10.1016/j.jcin.2017.02.028. Epub 2017 May 17.

16.

High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.

Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB; ARISTOTLE Investigators.

J Am Coll Cardiol. 2014 Jan 7-14;63(1):52-61. doi: 10.1016/j.jacc.2013.07.093. Epub 2013 Sep 19.

17.

Evidence that D-dimer levels predict subsequent thromboembolic and cardiovascular events in patients with atrial fibrillation during oral anticoagulant therapy.

Sadanaga T, Sadanaga M, Ogawa S.

J Am Coll Cardiol. 2010 May 18;55(20):2225-31. doi: 10.1016/j.jacc.2009.12.049.

18.

Delayed diagnosis of atrial fibrillation after first-ever stroke increases recurrent stroke risk: a 5-year nationwide follow-up study.

Chou PS, Ho BL, Chan YH, Wu MH, Hu HH, Chao AC.

Intern Med J. 2018 Jun;48(6):661-667. doi: 10.1111/imj.13686.

PMID:
29193638
19.

Unrecognized History of Transient Atrial Fibrillation at the Time of Discharge from an Index Stroke Hospitalization Is Associated with Increased Recurrent Stroke Risk.

Hsu CY, Singer DE, Kamel H, Wu YL, Chen PC, Lee JD, Lee M, Ovbiagele B.

J Stroke. 2019 May;21(2):190-194. doi: 10.5853/jos.2018.03265. Epub 2019 Apr 17.

20.

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.

Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.

J Am Coll Cardiol. 2014 Dec 16;64(23):2471-82. doi: 10.1016/j.jacc.2014.09.051.

Supplemental Content

Support Center